TY - JOUR
T1 - Clinical laboratory values as early indicators of ebola virus infection in nonhuman primates
AU - Reisler, Ronald B.
AU - Yu, Chenggang
AU - Donofrio, Michael J.
AU - Warren, Travis K.
AU - Wells, Jay B.
AU - Stuthman, Kelly S.
AU - Garza, Nicole L.
AU - Vantongeren, Sean A.
AU - Donnelly, Ginger C.
AU - Kane, Christopher D.
AU - Kortepeter, Mark G.
AU - Bavari, Sina
AU - Cardile, Anthony P.
N1 - Publisher Copyright:
© 2017, Centers for Disease Control and Prevention (CDC). All rights reserved.
PY - 2017/8
Y1 - 2017/8
N2 - The Ebola virus (EBOV) outbreak in West Africa during 2013–2016 demonstrated the need to improve Ebola virus disease (EVD) diagnostics and standards of care. This retrospective study compared laboratory values and clinical features of 3 nonhuman primate models of lethal EVD to assess associations with improved survival time. In addition, the study identified laboratory values useful as predictors of survival, surrogates for EBOV viral loads, and triggers for initiation of therapeutic interventions in these nonhuman primate models. Furthermore, the data support that, in nonhuman primates, the Makona strain of EBOV may be less virulent than the Kikwit strain of EBOV. The applicability of these findings as potential diagnostic and management tools for EVD in humans warrants further investigation.
AB - The Ebola virus (EBOV) outbreak in West Africa during 2013–2016 demonstrated the need to improve Ebola virus disease (EVD) diagnostics and standards of care. This retrospective study compared laboratory values and clinical features of 3 nonhuman primate models of lethal EVD to assess associations with improved survival time. In addition, the study identified laboratory values useful as predictors of survival, surrogates for EBOV viral loads, and triggers for initiation of therapeutic interventions in these nonhuman primate models. Furthermore, the data support that, in nonhuman primates, the Makona strain of EBOV may be less virulent than the Kikwit strain of EBOV. The applicability of these findings as potential diagnostic and management tools for EVD in humans warrants further investigation.
UR - http://www.scopus.com/inward/record.url?scp=85025107816&partnerID=8YFLogxK
U2 - 10.3201/eid2308.170029
DO - 10.3201/eid2308.170029
M3 - Article
C2 - 28726603
AN - SCOPUS:85025107816
SN - 1080-6040
VL - 23
SP - 1316
EP - 1324
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 8
ER -